Lawrence Eichenfield, MD

Lawrence Eichenfield, MD, Chief, Pediatric and Adolescent Dermatology,

Rady Children‘s Hospital-San Diego

Articles by Lawrence Eichenfield, MD

Lawrence Eichenfield, MD, discusses roflumilast success in pediatric atopic dermatitis

March 16th 2026

The INTEGUMENT-OLE study results highlight the long-term efficacy and safety of roflumilast cream for pediatric patients with atopic dermatitis.

Lawrence Eichenfield, MD, Rocco Serrao, MD, react to roflumilast approval for pediatric atopic dermatitis | Image credit: Contemporary Pediatrics

Lawrence Eichenfield, MD; and Rocco Serrao, MD, react to roflumilast approval for pediatric atopic dermatitis

ByLawrence Eichenfield, MD,Rocco Serrao, MD

October 7th 2025

A pair of roflumilast clinical trial investigators react to the FDA approval of the 0.05% formulation to treat atopic dermatitis in children aged 2 to 5 years.

Lawrence Eichenfield, MD

Articles by Lawrence Eichenfield, MD

Lawrence Eichenfield, MD, discusses roflumilast success in pediatric atopic dermatitis

Lawrence Eichenfield, MD; and Rocco Serrao, MD, react to roflumilast approval for pediatric atopic dermatitis

Latest Updated Articles

Trending on Contemporary Pediatrics

Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation

Colleen Cotton, MD, on the importance of early recognition in hidradenitis suppurativa

FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults

FDA accepts mavacamten (Camzyos) application for adolescent obstructive hypertrophic cardiomyopathy

Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa